Gilder Gagnon Howe & CO LLC Procept Bio Robotics Corp Transaction History
Gilder Gagnon Howe & CO LLC
- $8.56 Billion
- Q4 2024
A detailed history of Gilder Gagnon Howe & CO LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 37,822 shares of PRCT stock, worth $2.35 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
37,822Holding current value
$2.35 Million% of portfolio
0.04%Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
295Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$320 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$217 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$109 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$92.8 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$75.1 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.78B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...